‘We don’t pay patients for what we do’

Anne Jones of Genomics Medicine Ireland wants your DNA, and insists it will be ‘rigorously’ protected

17th March, 2019
Anne Jones, chief executive at GMI Picture: Bryan Meade

Medical research company Genomics Medicine Ireland (GMI) will go for an initial public offering within the next two years.

Based in Dublin, GMI was acquired by Chinese genomics specialists WuXi Nextcode last November. The value of the deal was not disclosed, but the company committed to investing $400 million to GMI’s plan to sequence the genomes of 400,000 people in Ireland.

It costs about $2,500 for each genome sequenced, so GMI’s plan to map the...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Anton Savage: If it doesn’t fit, get out the drillbit

Aidan Regan: Fiscal deficit is not a concern, but we must widen the tax base

Elaine Byrne: FG’s knives come out behind a veil of gentlemanly conduct

John Walsh: Going electric comes with potential pitfalls as well as benefits

Transport John Walsh 1 day ago